Combo Dual Therapy Stent: Completed postmarketing study enrollment

OrbusNeich completed enrollment of 1,000 patients in the European REMEDEE Registry study to evaluate the Combo Dual Therapy Stent with a clinical follow up of up to 5 years. The Combo Dual Therapy Ste...